Developing New Drug-nebulizer Combination Products

Interested in the critical success factors and opportunities for bringing a new vibrating membrane nebulizer for a drug-device combination product to the market? This article highlights opportunities and pitfalls – starting from the evaluation phase, through the development phase, and finally during commercialization. More Info

Your innovative aerosol therapy – our drug-nebulizer expertise

Bite-sized videos for pharmaceutical companies developing an inhaled drug formulation and searching for an appropriate optimized nebulizer. This interview series provides considerations from the initial matching of drug and nebulizer to development and commercialization. More Info

eFlow Technology Platform

eFlow Technology Platform is a nebulizer platform based on eFlow Technology, PARI’s laser drilled vibrating membrane technology platform. It provides low device risks and optimized aerosol performance for a wide range of drug formulations and is available with short lead times allowing for proceeding quickly into human trials. More Info

The eFlow Aerosol Chamber

The aerosol chamber is one of the key features of optimized drug-specific eFlow® Technology nebulizers. It enables short nebulization times as well as a high drug delivery efficiency. Click the link to the video to learn more about the aerosol chamber’s principle. More Info

Optimized eFlow Technology Nebulizers with Digital Therapy Management

PARI’s optimized vibrating membrane nebulizers based on eFlow® Technology consist of a drug-specific nebulizer handset and a controller—e.g., the eBase® Controller or the Bluetooth® and wi-fi ready eTrack® Controller. The latter can be complemented by digital supporting products like apps for patients and an online dashboard for physicians or study personnel. More Info